Back to search

University of Birmingham

Study of underlying mechanisms of NK cell impairment in B-CLL patients

Abstract

dc:description.abstract

Despite the potent role of NK cells in eliminating the tumor and leukemic cells, NK cells in B-CLL patients are dysfunctional and impaired, which contributes to the disease progression and B-CLL patients’ mortality. NK cell impairment has been linked at least to the downregulation of activating receptors on NK cells in B-CLL patients. The first part of this study has investigated further the phenotype of NK cells and detailed functionality of NK cells from B-CLL patients. The data showed that the expression of checkpoint receptors on NK cells were significantly upregulated, including PD-1,CTLA-4, LAG-3 and CD96. Also, NK cells from B-CLL patients demonstrated reduced cytokine production and impaired DNAM-1 dependent NK cell cytotoxicity compared to age-matched healthy controls. In addition, TIGIT and/or CD96 blockades can robustly reverse the DNAM-1 dependent NK cytotoxicity against tumor cell lines. The second part of this study focused on PD-1positive NK cells. At first, scRNA-seq analysis revealed that PD-1pos NK cells have differentiated transcription profile compared to PD-1neg NK cells, which can be used to identify new potential therapeutic targets to reverse anti-tumor functions of PD-1pos NK cells. Secondly, the functionality of PD-1pos NK cells was compared with PD-1neg NK cells using primary NK cells and NK cell line models. The function of PD-1pos NK cells were significantly impaired compared to PD-1neg counterparts, including lower expression of cytokine and cytotoxicity against tumor cell lines. Interestingly, blocking of PD-1/PD-1Ls interactions have partially reversed the anti-tumor activity of PD-1pos NK cells. This study revealed for the first time that the checkpoint receptors expression on NK cells from B-CLL are upregulated and blocking PD-1 or TIGIT/CD96 receptors might be potential novel strategies for NK cell based immunotherapy for B-CLL patients.

Degree

thesis:*
Name dc:type.qualificationname
d_ph
Level dc:type.qualificationlevel
d_ph
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Farhat, Mustafa

Subjects

dc:subject × 1

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Farhat, Mustafa. Study of underlying mechanisms of NK cell impairment in B-CLL patients. d_ph thesis, University of Birmingham, 2022.